{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:35:43Z","timestamp":1794580543932,"version":"4.9.1"},"reference-count":53,"publisher":"American Society of Hematology","issue":"7","license":[{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4,9]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Recombination-activating genes (RAG1 and RAG2) are critical for lymphoid cell development and function by initiating the variable (V), diversity (D), and joining (J) (V(D)J)-recombination process to generate polyclonal lymphocytes with broad antigen specificity. The clinical manifestations of defective RAG1\/2 genes range from immune dysregulation to severe combined immunodeficiencies (SCIDs), causing life-threatening infections and death early in life without hematopoietic cell transplantation (HCT). Despite improvements, haploidentical HCT without myeloablative conditioning carries a high risk of graft failure and incomplete immune reconstitution. The RAG complex is only expressed during the G0-G1 phase of the cell cycle in the early stages of T- and B-cell development, underscoring that a direct gene correction might capture the precise temporal expression of the endogenous gene. Here, we report a feasibility study using the CRISPR\/Cas9-based \u201cuniversal gene-correction\u201d approach for the RAG2 locus in human hematopoietic stem\/progenitor cells (HSPCs) from healthy donors and RAG2-SCID patient. V(D)J-recombinase activity was restored after gene correction of RAG2-SCID-derived HSPCs, resulting in the development of T-cell receptor (TCR) \u03b1\u03b2 and \u03b3\u03b4 CD3+ cells and single-positive CD4+ and CD8+ lymphocytes. TCR repertoire analysis indicated a normal distribution of CDR3 length and preserved usage of the distal TRAV genes. We confirmed the in\u00a0vivo rescue of B-cell development with normal immunoglobulin M surface expression and a significant decrease in CD56bright natural killer cells. Together, we provide specificity, toxicity, and efficacy data supporting the development of a gene-correction therapy to benefit RAG2-deficient patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023011766","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T18:13:16Z","timestamp":1702577596000},"page":"1820-1833","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":10,"title":["Genetically corrected\n                    <i>RAG2<\/i>\n                    -SCID human hematopoietic stem cells restore V(D)J-recombinase and rescue lymphoid deficiency"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2719-2498","authenticated-orcid":false,"given":"Mara","family":"Pavel-Dinu","sequence":"first","affiliation":[{"name":"1Division of Oncology, Hematology, Stem Cell Transplantation, Department of Pediatrics, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron L.","family":"Gardner","sequence":"additional","affiliation":[{"name":"2Immune Deficiency Genetics Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD"},{"name":"3Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6943-3811","authenticated-orcid":false,"given":"Yusuke","family":"Nakauchi","sequence":"additional","affiliation":[{"name":"4Division of Hematology, Department of Medicine, Cancer Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Kawai","sequence":"additional","affiliation":[{"name":"2Immune Deficiency Genetics Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4772-0799","authenticated-orcid":false,"given":"Ottavia M.","family":"Delmonte","sequence":"additional","affiliation":[{"name":"2Immune Deficiency Genetics Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2499-8250","authenticated-orcid":false,"given":"Boaz","family":"Palterer","sequence":"additional","affiliation":[{"name":"2Immune Deficiency Genetics Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marita","family":"Bosticardo","sequence":"additional","affiliation":[{"name":"2Immune Deficiency Genetics Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4537-9061","authenticated-orcid":false,"given":"Francesca","family":"Pala","sequence":"additional","affiliation":[{"name":"2Immune Deficiency Genetics Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5085-443X","authenticated-orcid":false,"given":"Sebastien","family":"Viel","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Hematology, Stem Cell Transplantation, Department of Pediatrics, Stanford University, Stanford, CA"},{"name":"5Service d\u2019immunologie biologique, Hospices Civils de Lyon, Centre International de Recherche en Infectivologie, Centre International de Recheerche in Infectivalogie, INSERM U1111, Universit\u00e9 Claude Bernard Lyon 1, Centre National de la Recherge Scientifique, UMR5308, \u00c9cole Normale Sup\u00e9rieure de Lyon, University of Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5874-5775","authenticated-orcid":false,"given":"Harry L.","family":"Malech","sequence":"additional","affiliation":[{"name":"6Genetic Immunotherapy Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4102-2367","authenticated-orcid":false,"given":"Hana Y.","family":"Ghanim","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Hematology, Stem Cell Transplantation, Department of Pediatrics, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Bode","sequence":"additional","affiliation":[{"name":"7Integrated DNA Technologies, Inc, Coralville, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4047-1427","authenticated-orcid":false,"given":"Gavin L.","family":"Kurgan","sequence":"additional","affiliation":[{"name":"7Integrated DNA Technologies, Inc, Coralville, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7026-5467","authenticated-orcid":false,"given":"Angela M.","family":"Detweiler","sequence":"additional","affiliation":[{"name":"8Chan Zuckerberg Biohub, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8510-4332","authenticated-orcid":false,"given":"Christopher A.","family":"Vakulskas","sequence":"additional","affiliation":[{"name":"7Integrated DNA Technologies, Inc, Coralville, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma F.","family":"Neff","sequence":"additional","affiliation":[{"name":"8Chan Zuckerberg Biohub, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Sheikali","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Hematology, Stem Cell Transplantation, Department of Pediatrics, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherah T.","family":"Menezes","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Hematology, Stem Cell Transplantation, Department of Pediatrics, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade","family":"Chrobok","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Hematology, Stem Cell Transplantation, Department of Pediatrics, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine M.","family":"Hern\u00e1ndez Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Hematology, Stem Cell Transplantation, Department of Pediatrics, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra","family":"Majeti","sequence":"additional","affiliation":[{"name":"4Division of Hematology, Department of Medicine, Cancer Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8335-0262","authenticated-orcid":false,"given":"Luigi D.","family":"Notarangelo","sequence":"additional","affiliation":[{"name":"2Immune Deficiency Genetics Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew H.","family":"Porteus","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Hematology, Stem Cell Transplantation, Department of Pediatrics, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,4,9]]},"reference":[{"key":"2024040915201806600_bib1","doi-asserted-by":"crossref","first-page":"15061","DOI":"10.1038\/nrdp.2015.61","article-title":"Severe combined immunodeficiencies and related disorders","volume":"1","author":"Fischer","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"2024040915201806600_bib2","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/humu.20408","article-title":"RAG-dependent primary immunodeficiencies","volume":"27","author":"Sobacchi","year":"2006","journal-title":"Hum Mutat"},{"issue":"4","key":"2024040915201806600_bib3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nri.2016.28","article-title":"Human RAG mutations: biochemistry and clinical implications","volume":"16","author":"Notarangelo","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"2024040915201806600_bib4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s10875-018-0537-4","article-title":"RAG Deficiency: two genes, many diseases","volume":"38","author":"Delmonte","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"issue":"2","key":"2024040915201806600_bib5","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jaci.2018.04.027","article-title":"Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotype","volume":"143","author":"Tirosh","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"11","key":"2024040915201806600_bib6","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1172\/JCI25221","article-title":"A\u00a0variant of SCID with specific immune responses and predominance of gamma delta T cells","volume":"115","author":"Ehl","year":"2005","journal-title":"J\u00a0Clin Invest"},{"issue":"11","key":"2024040915201806600_bib7","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1172\/JCI80477","article-title":"Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency","volume":"125","author":"Walter","year":"2015","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"2024040915201806600_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jaci.2018.08.027","article-title":"The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018)","volume":"143","author":"Dvorak","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"8","key":"2024040915201806600_bib9","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1182\/blood-2010-02-267583","article-title":"Hypomorphic Rag mutations can cause destructive midline granulomatous disease","volume":"116","author":"De Ravin","year":"2010","journal-title":"Blood"},{"issue":"2","key":"2024040915201806600_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10875-014-0121-5","article-title":"Identification of patients with RAG mutations previously diagnosed with common variable immunodeficiency disorders","volume":"35","author":"Buchbinder","year":"2015","journal-title":"J\u00a0Clin Immunol"},{"issue":"19","key":"2024040915201806600_bib11","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1056\/NEJMoa073966","article-title":"An immunodeficiency disease with RAG mutations and granulomas","volume":"358","author":"Schuetz","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"2024040915201806600_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1182\/blood-2013-01-476432","article-title":"SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID","volume":"123","author":"Schuetz","year":"2014","journal-title":"Blood"},{"issue":"17","key":"2024040915201806600_bib13","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1182\/blood-2018-03-840702","article-title":"SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery","volume":"132","author":"Haddad","year":"2018","journal-title":"Blood"},{"issue":"5","key":"2024040915201806600_bib14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency, 2000-2009","volume":"371","author":"Pai","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"2024040915201806600_bib15","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.jaci.2021.10.017","article-title":"Hematopoietic cell transplantation in severe combined immunodeficiency: the SCETIDE 2006-2014 European cohort","volume":"149","author":"Lankester","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"2024040915201806600_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/imr.12713","article-title":"RAG gene defects at the verge of immunodeficiency and immune dysregulation","volume":"287","author":"Villa","year":"2019","journal-title":"Immunol Rev"},{"issue":"12","key":"2024040915201806600_bib17","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1182\/bloodadvances.2020001730","article-title":"Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia","volume":"4","author":"Bosticardo","year":"2020","journal-title":"Blood Adv"},{"key":"2024040915201806600_bib18","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3389\/fimmu.2017.00798","article-title":"Natural killer cells from patients with recombinase-activating gene and non-homologous end joining gene defects comprise a higher frequency of CD56(bright) NKG2A(+++) cells, and yet display increased degranulation and higher perforin content","volume":"8","author":"Dobbs","year":"2017","journal-title":"Front Immunol"},{"issue":"9","key":"2024040915201806600_bib19","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/leu.2011.106","article-title":"Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer","volume":"25","author":"Pike-Overzet","year":"2011","journal-title":"Leukemia"},{"issue":"4","key":"2024040915201806600_bib20","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jaci.2013.10.009","article-title":"Recombination-activating gene 1 (Rag1)-deficient mice with severe combined immunodeficiency treated with lentiviral gene therapy demonstrate autoimmune Omenn-like syndrome","volume":"133","author":"van Til","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"10","key":"2024040915201806600_bib21","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1038\/mt.2012.110","article-title":"Correction of murine Rag2 severe combined immunodeficiency by lentiviral gene therapy using a codon-optimized RAG2 therapeutic transgene","volume":"20","author":"van Til","year":"2012","journal-title":"Mol Ther"},{"issue":"6096","key":"2024040915201806600_bib22","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A\u00a0programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"issue":"9","key":"2024040915201806600_bib23","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nbt.3290","article-title":"Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells","volume":"33","author":"Hendel","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"8","key":"2024040915201806600_bib24","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/s41591-018-0137-0","article-title":"A\u00a0high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells","volume":"24","author":"Vakulskas","year":"2018","journal-title":"Nat Med"},{"issue":"10","key":"2024040915201806600_bib25","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMra1800729","article-title":"A\u00a0new class of medicines through DNA editing","volume":"380","author":"Porteus","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"2024040915201806600_bib26","doi-asserted-by":"crossref","first-page":"eaaz0571","DOI":"10.1126\/sciadv.aaz0571","article-title":"CRISPR-based gene editing enables FOXP3 gene repair in IPEX patient cells","volume":"6","author":"Goodwin","year":"2020","journal-title":"Sci Adv"},{"issue":"21","key":"2024040915201806600_bib27","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1182\/blood-2015-11-683235","article-title":"Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome","volume":"127","author":"Hubbard","year":"2016","journal-title":"Blood"},{"issue":"3","key":"2024040915201806600_bib28","doi-asserted-by":"crossref","first-page":"e13545","DOI":"10.15252\/emmm.202013545","article-title":"Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper-IgM syndrome","volume":"13","author":"Vavassori","year":"2021","journal-title":"EMBO Mol Med"},{"issue":"1","key":"2024040915201806600_bib29","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41467-019-09614-y","article-title":"Gene correction for SCID-X1 in long-term hematopoietic stem cells","volume":"10","author":"Pavel-Dinu","year":"2019","journal-title":"Nat Commun"},{"issue":"6","key":"2024040915201806600_bib30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41434-021-00251-z","article-title":"Correction of X-CGD patient HSPCs by targeted CYBB cDNA insertion using CRISPR\/Cas9 with 53BP1 inhibition for enhanced homology-directed repair","volume":"28","author":"Sweeney","year":"2021","journal-title":"Gene Ther"},{"issue":"411","key":"2024040915201806600_bib31","doi-asserted-by":"crossref","first-page":"eaan0820","DOI":"10.1126\/scitranslmed.aan0820","article-title":"Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1","volume":"9","author":"Schiroli","year":"2017","journal-title":"Sci Transl Med"},{"issue":"4","key":"2024040915201806600_bib32","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/s41591-021-01284-y","article-title":"Gene replacement of alpha-globin with beta-globin restores hemoglobin balance in beta-thalassemia-derived hematopoietic stem and progenitor cells","volume":"27","author":"Cromer","year":"2021","journal-title":"Nat Med"},{"issue":"5","key":"2024040915201806600_bib33","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s10875-021-00989-6","article-title":"Gene editing rescues in\u00a0vitro t cell development of RAG2-deficient induced pluripotent stem cells in an artificial thymic organoid system","volume":"41","author":"Gardner","year":"2021","journal-title":"J\u00a0Clin Immunol"},{"key":"2024040915201806600_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.omtn.2022.12.006","article-title":"Multiplex HDR for disease and correction modeling of SCID by CRISPR genome editing in human HSPCs","volume":"31","author":"Iancu","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"issue":"12","key":"2024040915201806600_bib35","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1038\/mtna.2014.64","article-title":"COSMID: a web-based tool for identifying and validating CRISPR\/Cas off-target sites","volume":"3","author":"Cradick","year":"2014","journal-title":"Mol Ther Nucleic Acids"},{"key":"2024040915201806600_bib36","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1472-6750-11-80","article-title":"RNase H-dependent PCR (rhPCR): improved specificity and single nucleotide polymorphism detection using blocked cleavable primers","volume":"11","author":"Dobosy","year":"2011","journal-title":"BMC Biotechnol"},{"key":"2024040915201806600_bib37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ymeth.2017.03.021","article-title":"Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes","volume":"121-122","author":"Jacobi","year":"2017","journal-title":"Methods"},{"key":"2024040915201806600_bib38","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.omtm.2021.03.024","article-title":"CRISPAltRations: a validated cloud-based approach for interrogation of double-strand break repair mediated by CRISPR genome editing","volume":"21","author":"Kurgan","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"1","key":"2024040915201806600_bib39","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2119\/molmed.2011.00281","article-title":"Preserving the B-cell compartment favors operational tolerance in human renal transplantation","volume":"18","author":"Silva","year":"2012","journal-title":"Mol Med"},{"issue":"1","key":"2024040915201806600_bib40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nbt.4021","article-title":"Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiency","volume":"36","author":"Canny","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"19","key":"2024040915201806600_bib41","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1182\/blood.2020008503","article-title":"Enhanced homology-directed repair for highly efficient gene editing in hematopoietic stem\/progenitor cells","volume":"137","author":"De Ravin","year":"2021","journal-title":"Blood"},{"issue":"5667","key":"2024040915201806600_bib42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.1093933","article-title":"Development of a human adaptive immune system in cord blood cell-transplanted mice","volume":"304","author":"Traggiai","year":"2004","journal-title":"Science"},{"issue":"1","key":"2024040915201806600_bib43","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jaci.2018.05.028","article-title":"PROMIDISalpha: a T-cell receptor alpha signature associated with immunodeficiencies caused by V(D)J recombination defects","volume":"143","author":"Berland","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"2024040915201806600_bib44","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cell.2014.08.026","article-title":"The RAG recombinase dictates functional heterogeneity and cellular fitness in natural killer cells","volume":"159","author":"Karo","year":"2014","journal-title":"Cell"},{"key":"2024040915201806600_bib53","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3389\/fimmu.2017.00798","article-title":"Corrigendum: natural killer cells from patients with recombinase-activating gene and non-homologous end joining gene deffects comprise a higher frequency of CD56bright NKG2A+++ cells, and yet display increased degranulation and higher perforin content","volume":"8","author":"Dobbs","year":"2017","journal-title":"Front Immunol"},{"key":"2024040915201806600_bib45","doi-asserted-by":"crossref","first-page":"659761","DOI":"10.3389\/fimmu.2021.659761","article-title":"The interplay between chromatin architecture and lineage-specific transcription factors and the regulation of Rag gene expression","volume":"12","author":"Miyazaki","year":"2021","journal-title":"Front Immunol"},{"key":"2024040915201806600_bib46","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.omtm.2020.03.016","article-title":"Successful preclinical development of gene therapy for recombinase-activating gene-1-deficient SCID","volume":"17","author":"Garcia-Perez","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"44","key":"2024040915201806600_bib47","doi-asserted-by":"crossref","first-page":"E6020","DOI":"10.1073\/pnas.1519118112","article-title":"Development of a diverse human T-cell repertoire despite stringent restriction of hematopoietic clonality in the thymus","volume":"112","author":"Brugman","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"2024040915201806600_bib48","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.4049\/jimmunol.2100141","article-title":"Cutting edge: TCR-beta selection is required at the cd4(+)cd8(+) stage of human T cell development","volume":"206","author":"Chen","year":"2021","journal-title":"J\u00a0Immunol"},{"issue":"12","key":"2024040915201806600_bib49","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1182\/bloodadvances.2020001736","article-title":"Diagnostic assay to assist clinical decisions for unclassified severe combined immune deficiency","volume":"4","author":"Bifsha","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"2024040915201806600_bib50","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaci.2020.04.033","article-title":"Efficacy and safety of anti-CD45-saporin as conditioning agent for RAG deficiency","volume":"147","author":"Castiello","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"11","key":"2024040915201806600_bib51","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1182\/blood.2021012366","article-title":"A\u00a0CD45-targeted antibody-drug conjugate successfully conditions for allogeneic hematopoietic stem cell transplantation in mice","volume":"139","author":"Saha","year":"2022","journal-title":"Blood"},{"issue":"598","key":"2024040915201806600_bib52","doi-asserted-by":"crossref","first-page":"eabf2444","DOI":"10.1126\/scitranslmed.abf2444","article-title":"Development of beta-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease","volume":"13","author":"Lattanzi","year":"2021","journal-title":"Sci Transl Med"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/7\/1820\/2220804\/blooda_adv-2023-011766-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/7\/1820\/2220804\/blooda_adv-2023-011766-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T11:20:45Z","timestamp":1712661645000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/7\/1820\/506628\/Genetically-corrected-RAG2-SCID-human"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,9]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,4,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023011766","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.07.12.499831","asserted-by":"object"}]},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,9]]}}}